Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

Featured Articles | Featured Partners | Videos | Industry News | Events

July 08, 2021

Newsletter Sponsor

Control Changes the Formulation Game

Disruption is inevitable, but how well you maintain control can be a game-changer. With our Emprove® Program, you can better control disruption and maximize predictability. To support full supply chain transparency and risk mitigation, we provide online access to comprehensive documentation. Access the information you need when you need it.

We help you stay in control:

Full supply chain transparency
Risk assessment and management
More than 400 excipients for your speci?c formulation requirements

	Industry News

IRISYS, LLC’s New Liposomal Anticancer Drug Delivery System Receives Patent

Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence and Expand Testing Services

Eurofins Discovery and ImmunoPrecise Collaborate on Antibody Discovery Platform

ViiV Healthcare and Halozyme Enter Agreement for ENHANZE® Drug Delivery Technology to Develop “Ultra Long-Acting” HIV Medications

Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury

ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific

	Featured Articles

Strengthening Biopharma’s Resilience At a time when a robust global biopharma industry is critical, the global pandemic has exposed some of its weaknesses, as well as its strengths. New industry research shows that in our interconnected ... read more »

Adding State Licensing to Your Cell and Gene Launch Strategy We know that the cell and gene therapy market is growing. In Q1 of this year, a report was released stating that the market is projected to reach $25 billion by 2027 and acknowledging that with more ... read more »

	Featured Partners

Live webinar: Challenges and Considerations of Highly Potent Oral Solids.

Join Pfizer CentreOne experts as they discuss our technologies and processes for highly potent oral solids, which are delivered to the highest quality and safety standards. Register your attendance here. read more »

	Featured Video

On-Demand Webinar: IDAS: An Innovative Tool to Study Dissolution and Permeation of Orally Administered Dosage Forms
Live Webinar: IDAS: An Innovative Tool to Study Dissolution and Permeation of Orally Administered Dosage Forms read more »

On-Demand Webinar: Formulating to Enable High Concentration mAb Stability
Live Webinar: Formulating to Enable High Concentration mAb Stability read more »

	Featured Whitepaper

New Opportunities for Oral Sustained Release Formulations with Polyvinyl Alcohol This white paper describes the use of PVA-based Parteck® SRP 80, a functional excipient specifically developed for matrix-based sustained release oral... read more »

	Events

Oligonucleotide Therapeutics and Delivery Conference 2021
London, UK – 09/22/2021
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA,... event details »

Pre-filled Syringes San Francisco 2021
San Francisco, CA – 09/13/2021
As part of SMi’s leading Injectables series, this year’s event will address the key drivers of the pre-filled syringes and combination products ... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA